Trial Profile
Prospective Trial of Conversion From Tacrolimus to Sirolimus in African American Renal Transplant Recipients With Chronic Allograft Nephropathy.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 31 Oct 2009 New trial record